Source:
http://www.medscape.com/viewarticle/731048
http://www.medscape.com/viewarticle/731048
Laurie Barclay, MD
October 22, 2010 — Three biomarkers that can be tested in a single blood sample may help identify patients at high risk for chronic kidney disease (CKD), according to the results of a study reported online October 21 in the Journal of the American Society of Nephrology.
"[CKD] affects 13 percent of the adult population in the United States and is an important risk factor for cardiovascular disease," lead author Caroline S. Fox, MD, MPH, from the National Heart, Lung, and Blood Institute's Framingham Heart Study, in Massachusetts, said in a news release. "It is difficult to identify early abnormalities using serum creatinine, the most commonly used measure to assess kidney function.... Our results identify biomarkers that can improve CKD risk prediction."
